Research Article
The Value of Safflower Yellow Injection for the Treatment of Acute Cerebral Infarction: A Randomized Controlled Trial
Table 1
Baseline characteristics of study patients.
| | Characteristics | Control group | Safflower Yellow Injection group | value | | = 97 | = 31 | = 66 |
| | Male | 9 | 28 | 0.595 | | Mean age and range, years | 58.84 ± 10.18 (30–70) | 59.47 ± 10.92 (31–70) | 0.564 | | Body height/cm | Male | 170.00 ± 6.69 | 168.04 ± 6.07 | 0.573 | | Female | 159.19 ± 4.82 | 159.86 ± 4.86 | 0.554 | | Body weight/kg | Male | 67.56 ± 9.48 | 67.34 ± 9.85 | 0.563 | | Female | 58.73 ± 8.18 | 60.92 ± 8.44 | 0.612 | | Weight index/(kg/m2) | 23.19 ± 2.49 | 23.79 ± 2.76 | 0.963 | | Disease time/d | 5.00 ± 3.55 | 3.91 ± 2.77 | 0.925 | | NIH stroke scale score | 7.65 ± 2.32 | 8.53 ± 3.30 | 0.556 |
|
|
Values are mean ± S.D.; no significant changes between control group and Safflower Yellow Injection group.
|
